Vatinoxan
Vatinoxan (MK-467) is an alpha 2-adrenergic receptor antagonist. The peripheral selectivity of Vatinoxan determines that it has limited penetration across the blood-brain barrier and therefore has low concentrations in the central nervous system. Vatinoxan antagonizes alpha 2-adrenergic receptor receptors by binding to them, thereby reducing or preventing cardiovascular effects caused by α2-adrenergic agonists. Vatinoxan can be used in studies of cardiovascular effects, sedation and analgesia[1].
Product Specifications
CAS Number
114914-42-0
Product Name Alternative
MK-467; L-659066
UNSPSC
12352005
Target
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/vatinoxan.html
Smiles
CS(=O)(NCCN([C@]1(CN2)CCN3CCC4=C(OC5=CC=CC=C54)[C@]3([H])C1)C2=O)=O
Molecular Formula
C20H26N4O4S
Molecular Weight
418.51
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![2-Bromodibenzo[b,d]thiophene](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
Anti-PLBD2 Antibody Picoband®, HRP Conjugate
C4B (Complement Component 4B (Chido Blood Group), C4A, C4A13, C4A91, C4B1, C4B12, C4B2, C4B3, C4B5, C4F, CH, CO4, CPAMD3, FLJ60561, MGC164979) (HRP)
C4B (Complement Component 4B (Chido Blood Group), C4A, C4A13, C4A91, C4B1, C4B12, C4B2, C4B3, C4B5, C4F, CH, CO4, CPAMD3, FLJ60561, MGC164979) (HRP)
Biotin-Linked Polyclonal Antibody to N-Acylsphingosine Amidohydrolase 2 (ASAH2)